Key statistics
As of last trade, Legend Biotech Corp (9LB:FRA) traded at 34.60, 16.11% above the 52 week low of 29.80 set on Jan 13, 2025.
52-week range
Open | 35.00 |
---|---|
High | 35.00 |
Low | 34.00 |
Bid | 34.80 |
Offer | 35.00 |
Previous close | 35.00 |
Average volume | 379.11 |
---|---|
Shares outstanding | 183.45m |
Free float | 180.37m |
P/E (TTM) | -- |
Market cap | 6.49bn USD |
EPS (TTM) | -1.91 USD |
Data delayed at least 15 minutes, as of Mar 13 2025 18:55 BST.
More ▼
- Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights
- Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results
- Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma
- Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights
- Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
- Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma
- Legend Biotech Appoints Alan Bash as President of CARVYKTI®
- Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results
- Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
More ▼